Abstract
The identification and characterization of the inducible form of cyclooxygenases (COX-2) stimulated the investigations to develop efficient, non-steroidal anti-inflammatory drugs (NSAIDs) with reduced side effects (essentially gastro-intestinal toxicity) compared to classical NSAIDs. This review focuses on the chemical and pharmacological properties (pre-clinical data) of marketed COX-2 inhibitors.
Keywords: cox-2 inhibitors, cox-2 selectivity, pre-clinical data
Mini-Reviews in Medicinal Chemistry
Title: First and Second Generations of COX-2 Selective Inhibitors
Volume: 4 Issue: 6
Author(s): Xavier de Leval, Fabien Julemont, Valerie Benoit, Michel Frederich, Bernard Pirotte and Jean-Michel Dogne
Affiliation:
Keywords: cox-2 inhibitors, cox-2 selectivity, pre-clinical data
Abstract: The identification and characterization of the inducible form of cyclooxygenases (COX-2) stimulated the investigations to develop efficient, non-steroidal anti-inflammatory drugs (NSAIDs) with reduced side effects (essentially gastro-intestinal toxicity) compared to classical NSAIDs. This review focuses on the chemical and pharmacological properties (pre-clinical data) of marketed COX-2 inhibitors.
Export Options
About this article
Cite this article as:
Leval de Xavier, Julemont Fabien, Benoit Valerie, Frederich Michel, Pirotte Bernard and Dogne Jean-Michel, First and Second Generations of COX-2 Selective Inhibitors, Mini-Reviews in Medicinal Chemistry 2004; 4 (6) . https://dx.doi.org/10.2174/1389557043403693
DOI https://dx.doi.org/10.2174/1389557043403693 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inflammatory Cells and Chronic Obstructive Pulmonary Disease
Current Drug Targets - Inflammation & Allergy From Fragment Screening to Potent Binders: Strategies for Fragment-to-Lead Evolution
Mini-Reviews in Medicinal Chemistry A Novel Prescription for Alzheimer’s Disease: Targeting Hypercoagulable States
Current Neurovascular Research Novel Therapeutic Approaches in Pancreatic Cancer Based on Genomic Alterations
Current Pharmaceutical Design Functional PLGA NPs for Oral Drug Delivery: Recent Strategies and Developments
Mini-Reviews in Medicinal Chemistry Therapeutic Strategies in Parkinsons Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Cardiac Adiposity and Cardiovascular Risk: Potential Role of Epicardial Adipose Tissue
Current Cardiology Reviews Development and Clinical Application of Peptide-Based Radiopharmaceuticals
Current Pharmaceutical Design Evaluation of Allergic Reactions Following Intravenous Infusion of Polyvalent Antivenom in Snakebite Patients
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Effects of Butyric Acid on the Differentiation, Proliferation, Apoptosis, and Autophagy of IPEC-J2 Cells
Current Molecular Medicine Illicium verum Extract Exhibited Anti-inflammatory Action in Rodents
Letters in Drug Design & Discovery The Antiplatelet and Antithrombotic Actions of Statins
Current Pharmaceutical Design Transmembrane Protein 166 and its Significance
Protein & Peptide Letters Roles for Cavities in Protein Structure: New Insights
Current Proteomics The Role of Oxidative Stress in Cerebral Aneurysm Formation and Rupture
Current Neurovascular Research The State of the Art on the Use of Oral Fluid as Alternative Specimen in Forensic Toxicology
Current Pharmaceutical Analysis The Use of DNA Microarray in the Pharmacogenetics of Antidepressants: Guidelines for a Targeted Approach
Current Genomics Modulation of Doxorubicin Mediated Growth Inhibition of Hepatocellular Carcinoma Cells by Platelet Lysates
Anti-Cancer Agents in Medicinal Chemistry Ibubrofen in the Treatment of Patent Ductus Arteriosus in Preterm Infants: What We Know, What We Still Do Not Know
Current Pharmaceutical Design A Review on Response of Immune System in Spinal Cord Injury and Therapeutic Agents useful in Treatment
Current Pharmaceutical Biotechnology